Synthetic Biologics
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.67-0.01-0.01-0.00-0.01-0.02-0.05-0.07-0.23-0.79-0.90-0.02
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
4.580.020.030.05-0.120.010.050.090.050.300.26-0.12
Price/Cash Flow ratio
-9.05-0.01-0.01-0.00-0.00-0.02-0.06-0.05-0.25-0.81-0.99-0.02
Price/Free Cash Flow ratio
-9.00-0.01-0.01-0.00-0.00-0.02-0.06-0.05-0.25-0.81-0.99-0.02
Price/Earnings Growth ratio
-0.12-0.00-0.000.000.000.000.000.000.00-0.08-0.130.00
Dividend Yield
N/AN/AN/AN/AN/A3346.83%63.00%189.52%45.09%N/AN/A3346.83%
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/A-3.62%8.49%-41.17%-69.44%-30.92%-1.84%-0.43%-0.04%6.75%N/A-69.44%
Return on Assets
-75.76%-103.34%-141.79%-121.14%-80.55%-44.34%-88.79%-119.41%-20.28%-27.39%-21.59%-80.55%
Return On Equity
-80.87%-207.03%-272.48%-708.84%1014.30%-45.52%-106.52%-125.05%-21.82%-37.97%-26.48%-26.48%
Return on Capital Employed
-81.01%-214.54%-268.36%-1432.03%-290.22%-65.66%-130.96%-186.62%-21.34%-33.30%-25.73%-290.22%
Liquidity Ratios
Current Ratio
15.781.981.941.091.838.723.112.67N/AN/A4.131.83
Quick Ratio
14.241.981.941.091.838.723.112.6719.376.443.961.83
Cash ratio
14.241.821.330.961.748.542.852.0918.945.913.941.74
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.06N/AN/AN/AN/AN/A0.040.050.020.020.25N/A
Debt Equity Ratio
0.06N/AN/AN/AN/AN/A0.050.050.020.030.33N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.030.020.020.020.02N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.040.050.020.030.02N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-592.56N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/A-19.21-25.72-8.44-11.35-9.55N/A
Company Equity Multiplier
1.062.001.925.85-12.591.021.191.041.071.381.33-12.59
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.011.021.011.0011.001.001.001.001.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/A-19.21-25.72-8.44-11.35-9.55N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A-55.71-42.39-103.95-69.89-88.17N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/A-87.38%-3.43%-13.74%-10.48%N/AN/AN/A